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INTRODUCTION
Dietary supplements with ginseng, or ginseng alone, 
are widely used for a broad range of conditions, includ-
ing erectile dysfunction. Compounds containing ginseng 
are some of the most popular and best-selling herbal 
medicines in the world [1]. They are used for a broad 
range of conditions including erectile dysfunction [2,3]. 
One systematic review presented evidence in support 
of red ginseng as a treatment for erectile dysfunction 
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[4]. Another systematic review analysis, published in 
2013, evaluated all current randomized controlled trials 
(RCTs) of ginseng in the Korean literature [5] included 
two additional Korean RCTs related to erectile dys-
function that were not included in the previous review 
[4], which had demonstrated positive effects of ginseng 
on erectile dysfunction. Thus, there is a need for a well-
organized and up-to-date systematic review to evaluate 
the efficacy of ginseng for erectile dysfunction. This 
review critically appraises the current evidence regard-
ing the use of ginseng to treat erectile dysfunction.
MATERIALS AND METHODS
We conducted systematic searches on multiple elec-
tronic databases, including CENTRAL, MEDLINE, 
Embase, CINAHL, AMED, trials registries, and locore-
gional databases of east Asia, from their inceptions 
to 30 January 2021 without restrictions on language 
and publication status using search strategies (for 
the search strategy, see Supplement Table 1). Hand 
searches included conference proceedings. We included 
randomized or quasi-randomized controlled trials that 
evaluated the use of any type of ginseng as a treat-
ment for erectile dysfunction compared to placebo or 
conventional treatment. Primary outcomes were erec-
tile function and adverse events. Secondary outcomes 
were ability to have intercourse reported by partici-
pants (or partner), sexual satisfaction, and quality of 
life. Two authors independently classified studies and 
three authors independently extracted data and as-
sessed risk of bias in the included studies. We conduct-
ed meta-analyses using a random-effects model and 
95% confidence intervals [CIs]. We interpreted random-
effects meta-analyses with due consideration of the 
whole distribution of effects. Also, we performed sta-
tistical analyses according to the statistical guidelines 
contained in the Cochrane Handbook [6]. We rated 
the certainty of evidence according to the GRADE ap-
proach.
Please see review published in Cochrane Library for 
further details on the methods [7].
No ethical approval was required for this manuscript 
as this study did not involve human subjects or labora-
tory animals.
RESULTS
We included nine studies [8-16] with 587 men with 
mild to moderate erectile dysfunction, aged from 20 to 
70 years old (Supplement Fig. 1). The studies all com-
pared ginseng to placebo. We found only short-term 
follow-up data (up to 12 weeks). Supplement Tables 
2 and 3 summarized the characteristics the included 
studies. The assessments of risk of bias were shown in 
Supplement Fig. 2. Supplement Table 4 list the exclud-
ed studies and their details reasons.
Primary outcomes: Ginseng appears to have a trivial 
effect on erectile dysfunction when compared to pla-
cebo based on the Erectile Function Domain of the In-
ternational Index of Erectile Function (IIEF)-15 instru-
ment (scale: 1 to 30, higher scores imply better function; 
mean difference [MD] 3.52, 95% CI 1.79 to 5.25; I2=0%; 
3 studies; low certainty evidence) assuming a minimal 
clinically important difference (MCID) of 4 (Table 1) 
[13,14,16,17]. Ginseng probably also has a trivial effect 
on erectile function when compared to placebo based 
on the IIEF-5 instrument (scale: 1 to 25, higher scores 
imply better function; MD 2.39, 95% CI 0.89 to 3.88; 
I2=0%; 3 studies; moderate certainty evidence) assum-
ing a MCID of 5 [12,14,16]. Ginseng may have little to 
no effect on adverse events compared to placebo (risk 
ratio [RR] 1.45, 95% CI 0.69 to 3.03; I2=0%; 7 studies; low 
certainty evidence) [8-14]. Based on 86 adverse events 
per 1,000 men in the placebo group, this would corre-
spond to 39 more adverse events per 1,000 (95% CI 27 
fewer to 174 more).
Secondary outcomes: Ginseng may improve men's 
self-reported ability to have intercourse (RR 2.55, 95% 
CI 1.76 to 3.69; I2=23%; 6 studies; low certainty evidence) 
[8-12,14]. Based on 207 per 1,000 men self-reporting the 
ability to have intercourse in the placebo group, this 
would correspond to 321 more men (95% CI 158 more 
to 558 more) per 1,000 self-reporting the ability to have 
intercourse. Ginseng may have a trivial effect on men's 
satisfaction with intercourse based on the Intercourse 
Satisfaction Domain of  the IIEF-15 (scale: 0 to 15, 
higher scores imply greater satisfaction; MD 1.19, 95% 
CI 0.41 to 1.97; I2=0%; 3 studies; low certainty evidence) 
based on a MCID of 25% improvement from baseline 
[13,14,16]. It may also have a trivial effect on men's sat-
isfaction with intercourse based on item 5 of the IIEF-5 
(scale: 0 to 5, higher scores imply more satisfaction; MD 
0.60, 95% CI 0.02 to 1.18; 1 study; low certainty evidence) 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































based on a MCID of 25% improvement from baseline 
[12]. No study reported quality of life as an outcome. 
We found no trial evidence to inform comparisons to 
other treatments for erectile dysfunction, such as phos-
phodiesterase-5 inhibitors. We were unable to conduct 
any predefined subgroup analyses.
DISCUSSION
Most of the included studies were conducted in South 
Korea. Currently, it is not known if growing regions 
(i.e., differences in soil and the environment) affect the 
therapeutic effects of ginseng by impacting the chemi-
cal formulation. It is unclear how applicable the find-
ings of this Cochrane Review may be to other forms 
of ginseng (i.e., American or Chinese ginseng) that are 
grown in other areas.
Most of the included studies used a ginseng dose of 
3,000 mg or less, which is less than the dose typically 
recommended by manufacturers. While there are no 
clear guidelines on the appropriate dosing of ginseng 
for erectile dysfunction, the small effects observed with 
ginseng in this review (which are less than the MCID), 
may be due to suboptimal doses for erectile dysfunc-
tion.
We consistently downgraded the certainty of the evi-
dence for study limitations. The most common reasons 
were lack of information on random sequence genera-
tion and allocation concealment, which are known to 
result in an overestimation of the effect size [18,19]. We 
further downgraded the certainty of the evidence for 
indirectness (different definitions in the questionnaires 
measuring the outcome) and imprecision (threshold of 
clinically important effect size or MCID and a wide CI). 
Lastly, we downgraded for imprecision in light of wide 
confidence intervals that crossed predefined thresholds 
of clinical importance. 
CONCLUSIONS
Based on mostly low certainty evidence, ginseng may 
only have trivial effects on erectile function or sat-
isfaction with intercourse compared to placebo when 
assessed using validated instruments. Ginseng may 
improve men's self-reported ability to have intercourse. 
It may have little to no effect on adverse events. We 
found no trial evidence comparing ginseng to other 
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dysfunction, such as phosphodiesterase-5 inhibitors.
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